Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 23:15:42.
doi: 10.1186/s13027-020-00307-6. eCollection 2020.

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer

Affiliations
Review

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer

Valli De Re et al. Infect Agent Cancer. .

Abstract

Background: EBV produces miRNAs with important functions in cancer growth, tumor invasion and host immune surveillance. The discovery of EBV miR-BARTs is recent, and most of their functions are still unknown. Nonetheless, some new studies underline their key roles in EBV-associated malignancies.

Main body: In EBV-associated tumors, the expression profile of miR-BARTs varies according to the cell type, autophagic process and signals received from the tumor microenvironment. By the same way of interest is the interaction between tumor cells and the tumor environment by the release of selected EBV miR-BARTs in addition to the tumor proteins trough tumor exosomes.

Conclusion: In this review, we discuss new findings regarding EBV miR-BARTs in Hodgkin lymphoma and gastric cancer. The recent discovery that miRNAs are released by exosomes, including miR-BARTs, highlights the importance of tumor and microenvironment interplay with more specific effects on the host immune response.

Keywords: BamHI fragment a rightward transcript; EBV; Epstein-Barr virus; miRNA; Gastric carcinoma cancer; HL; Hodgkin lymphoma; GC; Micro RNA; BART.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThere are no conflicts of interest in connection with this paper, and the material described is not under publication or consideration for publication elsewhere.

Figures

Fig. 1
Fig. 1
Genomic map of the EBV region containing the BAMHI-I fragment. miR-BamHI fragment H rightward open reading frame 1 (BHFR1), latent EBV-encoded nuclear antigen 3 (EBNA3), latent EBV-encoded nuclear antigen 1 (EBNA1), miR-BamHI A rightward transcripts (BARTs) in sequence order. Genomic deletion in the EBV B958.9 strain is shown. P1, promoter 1; P2, promoter 2; Qp, Q promoter are indicated by arrows

Similar articles

Cited by

References

    1. Khan G, Hashim MJ. Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010. Infect Agents Cancer. 2014;9:38. - PMC - PubMed
    1. Shannon-Lowe C, Adland E, Bell AI, Delecluse H-J, Rickinson AB, Rowe M. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol. 2009;83:7749–7760. - PMC - PubMed
    1. Chen J, Sathiyamoorthy K, Zhang X, Schaller S, Perez White BE, Jardetzky TS, et al. Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus. Nat Microbiol. 2018;3:172–180. - PMC - PubMed
    1. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to Oral epithelial cells. Virology. 2008;370:430–442. - PMC - PubMed
    1. Xiong D, Du Y, Wang H-B, Zhao B, Zhang H, Li Y, et al. Nonmuscle myosin heavy chain IIA mediates Epstein–Barr virus infection of nasopharyngeal epithelial cells. Proc Natl Acad Sci U S A. 2015;112:11036–11041. - PMC - PubMed

LinkOut - more resources